Cancers attributable to infection in the UK in 2010

British Journal of Cancer

Volumn 105, Issue , 2011, Pages S49-S56

  Parkin, D M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; CANCER RISK; DISEASE COURSE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; LIVER CANCER; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STOMACH CARCINOMA; STOMACH LYMPHOMA; UNITED KINGDOM; ALPHAPAPILLOMAVIRUS; FEMALE; HELICOBACTER PYLORI; HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LIVER TUMOR; MALE; NEOPLASM; VIROLOGY; VIRUS INFECTION;

ALPHAPAPILLOMAVIRUS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GREAT BRITAIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATITIS; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; INFECTION; LIVER NEOPLASMS; MALE; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; VIRUS DISEASES;

EID: 83255164119     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.484     Document Type: Article

References (79)

1. Armstrong AA, Weiss LM, Gallagher A, Jones DB, Krajewski AS, Angus B, Brown G, Jack AS, Wilkins BS, Onions DE (1992) Criteria for the definition of Epstein-Barr virus association in Hodgkin’s disease. Leukemia 6: 869–874
2. Balogun MA, Ramsay ME, Hesketh LM, Andrews N, Osborne KP, Gay NJ, Morgan-Capner P (2002) The prevalence of hepatitis C in England and Wales. J Infect 45: 219 –226
3. Banatvala N, Mayo K, Mégraud F, Jennings R, Deeks JJ, Feldman RA (1993) The cohort effect and Helicobacter pylori. J Infect Dis 168: 219–221
4. Beral V, Peterman T, Berkelman R, Jaffe H (1991) AIDS-associated non-Hodgkin lymphoma. Lancet 337: 805–809
5. Bezerra AL, Lopes A, Landman G, Alencar GN, Torloni H, Villa LL (2001) Clinicopathologic features and human papillomavirus DNA prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol 25: 673–678
6. Boshoff C, Weiss RA (2001) Epidemiology and pathogenesis of Kaposi’s sarcoma-associated herpesvirus. Phil Trans Roy Soc Lond B 356: 517–534
7. Casabona J, Melbye M, Biggar RJ, the AIDS Registry Contributors (1991) Kaposi’s sarcoma and non-Hodgkin’s lymphoma in European AIDS cases. Int J Cancer 47: 49–53
8. Centers for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 41: 1–19
9. Cho LY, Yang JJ, Ko PL, Park B, Shin A, Lim MK, Oh JK, Park S, Kim YJ, Shin HR, Yoo KY, Park SK (2011) Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. Int J Cancer 128: 176–184
10. Cole P, MacMahon B (1971) Attributable risk percent in case-control studies. Brit J Prev Soc Med 25: 242–244
11. Coté TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Geodert JJ, Blattner WA (1997) Non-Hodgkin’s lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 73: 645–650
12. Curado M, Edwards B, Shin H (2007) Cancer Incidence in Five Continents, Vol. I to XI. IARC Scientific Publications No. 160. IARC: Lyon
13. Dal Maso L, Franceschi S (2006) Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15: 2078–2085
14. Dal Maso L, Serraino D, Franceschi S (2001) Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 37: 1188–1201
15. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H (2002) A populationbased study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84: 263–270
16. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, Grulich AE, Cerhan JR, Hartge P, Cozen W, Boffetta P, Brennan P, Maynadié M, Cocco P, Bosch R, Foretova L, Staines A, Becker N, Nieters A (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6: 451–458
17. Donato F, Boffetta P, Puoti M (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75: 347–354
18. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123: 187–194
19. Evans AS, Gutensohn NM (1984) A population-based case control study of EBV and other viral antibodies among persons with Hodgkin’s disease and their siblings. Int J Cancer 34: 147–157
20. Frisch M, Biggar RJ, Engels EA, Goedert JJ (2001) AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285: 1736–1745
21. Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92: 1500–1510
22. Frisch M, Fenger C, van den Brule AJC, Sørensen P, Meijer CJLM, Walboomers JMM, Adami H-O, Melbye M, Glimelius B (1999) Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 59: 753–757
23. Gay NJ, Hesketh LM, Osborne KP, Farrington CP, Morgan-Capner P, Miller E (1999) The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect 122: 133 –138
24. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R (2003) Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis. Gastroenterology 125: 1723–1732
25. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O’Grady J, Hummel M, Preciado MV (1997) Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data. Int J Cancer 70: 375–382
26. Gledhill S, Gallagher A, Jones DB, Krajewski AS, Alexander FE, Klee E, Wright DH, O’Brien C, Onions DE, Jarrett RF (1991) Viral involvement in Hodgkin’s disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br J Cancer 64: 227–232
27. Goedert JJ, Coté TR (1995) Conjunctival malignant disease with AIDS in USA. Lancet 346: 257–258
28. Goedert JJ, Coté TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351: 1833–1839
29. Grulich AE, Beral V, Swerdlow AJ. (1992) Kaposi’s sarcoma in England and Wales before the AIDS epidemic. Br J Cancer 66: 1135–1137
30. Grulich AE, Li Y, McDonald A, Correl PK, Law MG, Kaldor JM (2002) Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16: 1155–1161
31. Gutierrez MI, Bhatia K, Barriga F, Diez B, Muriel FS, de Andreas ML, Epelman S, Risueno C, Magrath IT (1992) Molecular epidemiology of Burkitt’s lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 79: 3261–3266
32. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L, Pallesen G (1993) In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 82: 619–624
33. Health Protection Agency (HPA) (2006) Hepatitis C in England: An Update. Health Protection Agency Centre for Infections: London. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1196942171852
34. Health Protection Agency (HPA) (2009) NBS/Health Protection Agency Infection Surveillance. Six Month Summary Report No. 29: data to end of March 2009. Health Protection Agency: London. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1241418683965
35. Health Protection Agency (HPA) (2010) HIV in the United Kingdom: 2010 Report. Health Prot Rep 2010 4: 47. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1287145367237
36. Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case-control studies nested within prospective cohorts. Gut 49: 347–353
37. Herrero R, Munoz N (1999) Human papillomavirus and cancer. In Infections and Human Cancer. Cancer Surveys, Weiss RA, Beral V, Newton R (eds) Vol. 33, pp 75–98. Cold Spring Harbor Laboratory Press: Cold Spring Harbor
38. Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, Melnick S, Abulafia O, Levine AM; for the WIHS Collaborative Study Group (2004) Cancer risk among participants in the women’s interagency HIV study. J Acquir Immune Defic Syndr 36: 978–985
39. Hoover DR, Black C, Jacobson LP, Martinez-Maza O, Seminara D, Saah A, Von Roenn J, Anderson R, Armenian HK (1993) Epidemiologic analysis of Kaposi’s sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 138: 266–278
40. IARC (2005) Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 90, Human Papillomaviruses. IARC: Lyon
41. IARC (1994a) Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 61, Schistosomes, Liver Flukes and Helicobacter Pylori. IARC: Lyon
42. IARC (1994b) Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 59, Hepatitis Viruses. IARC: Lyon
43. IARC (1997) Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 70, Infections with Epstein-Barr Virus and Human Herpes Viruses. IARC: Lyon
44. IARC (1996) Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 67, Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses. IARC: Lyon
45. International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92: 1823–1830
46. Jarrett RF, Gallagher A, Jones DB, Alexander FE, Krajewski AS, Kelsey A, Adams J, Angus B, Gledhill S, Wright DH (1991) Detection of Epstein-Barr virus genomes in Hodgkin’s disease: relation to age. J Clin Pathol 44: 844–848
47. Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P, Heinonen OP (1997) Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 119: 29–34
48. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005a) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467–475
49. Kreimer AR, Clifford GM, Snijders PJ, Castellsagué X, Meijer CJ, Pawlita M, Viscidi R, Herrero R, International Agency for Research on Cancer (IARC) Multicenter Oral Cancer Study Group (2005b) HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int J Cancer 115: 329–332
50. Herrmann K, Niedobitek G. (2003) Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol 199: 140–145
51. Lenoir GM, Delecluse HJ (1989) Lymphoma and the immuno-compromised host. In Immune Disorders and Opportunistic Infections, Revillard J-P, Wierzbicki N (eds). Foundation Franco-Allemande: Suresness, pp 173–183
52. Lenoir GM, Philip T, Sohier R (1984) Burkitt-type lymphoma: EBV association and cytogenetic markers in cases from various geographic locations. In Pathogenesis of Leukaemias and Lymphomas: Environmental Influences, Progress in Cancer Research and Therapy, Magrath IT, O’Conor GT, Ramot B (eds), Vol. 27. Raven Press: New York
53. Lundgren JD, Melbye M, Pedersen C, Rosenberg PS, Gerstoff J (1995) Changing patterns of Kaposi’s sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. Am J Epidemiol 141: 652–658
54. Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, Kurman RJ, Beckmann AM, Hagensee ME, Galloway DA (1997) Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 89: 1516–1523
55. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE (2004) Effect of hepatitis C virus infection on the risk of non-Hodgkin’s lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 95: 745–752
56. Mitchell H, English DR, Elliott F, Gengos M, Barrett JH, Giles GG, Forman D (2008) Immunoblotting using multiple antigens is essential to demonstrate the true risk of Helicobacter pylori infection for gastric cancer. Aliment Pharmacol Ther 28: 903–910
57. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J (1989) Hodgkin’s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. New Engl J Med 320: 689–695
58. Mueller NE, Birmann B, Parsonnet J, Schiffman M, Stuver S (2005) Infectious agents. In Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni JF Jr (eds) 3rd edn. Oxford University Press: Oxford, UK
59. Newton R, Ferlay J, Beral V, Devesa SS (1997) The epidemiology of non-Hodgkin’s lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer 72: 923–930
60. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030–3044
61. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330: 1267–1271
62. Paterlini P, Gerken G, Nakajima E, Terre S, D’Errico A, Grigioni W, Nalpas B, Franco D, Wands J, Kew M (1990) Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 323: 80–85
63. Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S, Swiss HIV Cohort Study (2008) Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS 22: 301–306
64. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (2004) (eds). SEER Cancer Statistics Review, 1975–2001. National Cancer Institute: Bethesda, MD. http://seer.cancer.gov/csr/1975_2001/
65. Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, Vandenbroucke-Grauls CM (1997) Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 92: 1480–1482
66. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WGV, Pirog EC (2001) Detection and typing of human papillomavirus DNA in penile carcinoma. Am J Pathol 159: 1211–1218
67. Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G (1997) Cancer incidence in a cohort of human immunodeficiency virus seroconverters: HIV Italian seroconversion study group. Cancer 79: 1004–1008
68. Shah KV (1998) Do human papillomavirus infections cause oral cancer? J Natl Cancer Inst 90: 1585–1586
69. Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJ, Van Den Brule AJ, Franceschi S, Peeling RW (2004) IARC multicentric case-control study. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 111: 431–439
70. Takada K (2000) Epstein-Barr virus and gastric carcinoma. Mol Pathol 53: 255–261
71. Trimble CL, Hildesheim A, Brinton LA, Shah KV, Kurman RJ (1996) Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 87: 59–64
72. The UK Collaborative Group for HIV and STI Surveillance (UKCGHS) (2006) A Complex Picture. HIV and Other Sexually Transmitted Infections in the United Kingdom: 2006. Health Protection Agency Centre for Infections: London. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947365435
73. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH (2001) Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93: 232–235
74. van Lier EA, van Kranen HJ, van Vliet JA, Rahamat-Langendoen JC (2008) Estimated number of new cancer cases attributable to infection in the Netherlands in 2003. Cancer Lett 272: 226–231
75. Vyse AJ, Gay NJ, Hesketh LM, Andrews NJ, Marshall B, Thomas HI, Morgan-Capner P, Miller E (2002) The burden of Helicobacter pylori infection in England and Wales. Epidemiol Infect 128: 411–417
76. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19
77. Weinreb M, Day PJR, Niggli F, Powell JE, Raafat F, Hesseling PB, Schneider JW, Hartley PS, Tzortzatou-Stathopoulou F, Khalek ER, Mangoud A, El-Safy UR (1996) The role of Epstein-Barr virus in Hodgkin’s disease from different geographical areas. Arch Dis Child 74: 27–31
78. Weiss LM, Movahed LA, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. New Engl J Med 320: 502 –506
79. Ziegler JL, Drew WL, Miner RC, Mintz L, Rosenbaum E, Gershow J, Lennette ET, Greenspan J, Shillitoe E, Beckstead J, Casavant C, Yamamoto K (1982) Outbreak of Burkitt’s-like lymphoma in homosexual men. Lancet 2: 631–633